Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1119-1122
Number of pages4
JournalLeukemia
Volume26
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Hematopoietic Stem Cell Mobilization
Thalidomide
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Antineoplastic Agents
Cyclophosphamide
Therapeutics
lenalidomide

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

@article{0c14b03ebe8c4d9da153e9fca7c158c7,
title = "Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies",
author = "S. Sinha and Morie Gertz and Martha Lacy and Angela Dispenzieri and Hayman, {S. R.} and Buadi, {F. K.} and Dingli, {David M} and Ivana Micallef and William Hogan and Gastineau, {D. A.} and Rajkumar, {S Vincent} and Kumar, {Shaji K}",
year = "2012",
month = "5",
doi = "10.1038/leu.2011.308",
language = "English (US)",
volume = "26",
pages = "1119--1122",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

AU - Sinha, S.

AU - Gertz, Morie

AU - Lacy, Martha

AU - Dispenzieri, Angela

AU - Hayman, S. R.

AU - Buadi, F. K.

AU - Dingli, David M

AU - Micallef, Ivana

AU - Hogan, William

AU - Gastineau, D. A.

AU - Rajkumar, S Vincent

AU - Kumar, Shaji K

PY - 2012/5

Y1 - 2012/5

UR - http://www.scopus.com/inward/record.url?scp=84860716728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860716728&partnerID=8YFLogxK

U2 - 10.1038/leu.2011.308

DO - 10.1038/leu.2011.308

M3 - Article

C2 - 22033494

AN - SCOPUS:84860716728

VL - 26

SP - 1119

EP - 1122

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -